Abstract
Introduction
Characterization of tumor microenvironment holds a key role in the attempt to understand the mechanism of primary and secondary liver carcinogenesis, its immune component, responsible for the development of an immune response of the host against the tumor, being the main point of interest [1] [2] [3] [4] . The largely inconsistent biological behavior of primary and secondary liver tumors could be also explained by the settled relationship between the tumoral component and microenvironment [1, 5, 6] .
Although the role of lymphocytes in immunity was stated for the first time over one hundred years ago, the first report which proved the correlation between the increased number of cytotoxic CD8+ T lymphocytes and the favorable prognosis in melanoma tumor pathology had been published in 1989 [7] . The study on colorectal cancer showed the involvement of T lymphocytes in destruction of cancer cells within tumor and called them tumor-infiltrating lymphocytes (TILs) [8] . The ratios between CD4+ and CD8+ T lymphocytes within TILs are variable, depending not only on the investigated tumor type, but also on the quantification method. However, numerous studies on colorectal [9] , ovarian [10] , breast [11, 12] , and esophageal cancer [13] , leukemia [14] , and other malignancies confirmed the protective prognosis value of the immune infiltrate with CD8+ T lymphocytes [15] . Nevertheless, there are conflicting results, such as in melanoma, where TILs influence survival either positively [16, 17] or negatively [18, 19] .
All these data support the fact that despite concerted efforts towards the decoding of a stable pattern in the relationship between the presence of TILs and tumor behavior, the dilemma regarding the position of TILs as friend or foes [20] is still present. The review of the literature reveals attentiveness to the investigation of TILs in hepatic parenchyma, in primary tumor context -namely hepatocellular carcinoma (HCC) [3, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] or in liver metastases (LM) [33] [34] [35] . Nevertheless, we have to highlight the fact that none of the published studies presented comparative data of CD4+ and CD8+ T lymphocytes in primary versus secondary liver tumors.
Within this framework, our study focused on the investigation of the immune infiltrates in HCC and LM, using a comparative evaluation of intratumoral and peritumoral CD4+ and CD8+ T lymphocytes, respectively, with the aim to ascertain the value of their ratio as a prognostic factor.
Material and methods
Patients. The studied material consisted of paraffin-embedded tissue specimens corresponding to 35 patients with HCC (Group 1) and 39 patients with LM (Group 2) diagnosed and surgically treated between January 2009 and December 2011 at "Sf. Spiridon" University Hospital, Iaşi. The study was approved by the Ethics Committee of the University of Medicine and Pharmacy "Grigore T. Popa", Iaşi, Romania.
The clinicopathological features are presented in Table 1 ; the tumor stage and histological grade both for HCC and LM were established according to the criteria of pTNM classification [36] . The patients did not receive preoperative chemotherapy or radiotherapy.
All documented patients' deaths were related to previously diagnosed cancer disease. The median survival rates were 5 months for HCC and 17 months for LM cases. According to follow-up records, 36 Quantitative analysis. TILs were assessed by using an adapted methodology [37] . 
Results

Qualitative analysis of T cells populations in HCC and LM
The microscopic examination revealed both in HCC (Group 1) and LM (Group 2) a similar distribution pattern for CD4+ and CD8+ T lymphocytes, with an obvious cellular predominance in the PT area, especially at the border with normal liver parenchyma (tumor's invasion front), compared with IT localization ( Figure 1A-D) . We noted a specific PT arrangement of CD4+ and CD8+ T lymphocytes, around the tumoral islands, as condensed layers or mantle zones, or as compact structures resembling lymphoid nodules, whereas they were isolated or dispersed within the tumoral mass. When the T lymphocytes' populations were divided according to intra-or peritumoral location, we observed a significant prevalence of T cells in peritumoral over intratumoral tissue. In HCC the PT/IT ratio was 3.5 for CD8+ (PT mean value 231.70 ± 162.66 vs. IT mean value 65.3 ± 65.4) and 5.5 for CD4+ cells (PT mean value 237.05 ± 149.77 vs. IT mean value 43.10 ± 52.39); statistical analysis revealed significant differences for both CD4+ and CD8+ lymphocytes, intratumoral vs. peritumoral (p < 0.0001); no significant differences were found between CD4+ and CD8+ cells, when we compared their number in IT and PT areas, respectively (Figure 2A) . In LM the ratios were 4.3 for CD8+ (PT mean value 176.00 ± 120.13 vs. IT mean value 41.10 ± 0.47) and 10.0 for CD4+ cells (PT mean value 109.9 ± 160.93 vs. IT mean value 11.00 ± 1.55); statistical analysis revealed significant differences between IT and PT area for both CD4+ and CD8+ cells (p < 0.0001), and also between CD4+ and CD8+ cells, in IT (p < 0.0001) and PT areas (p < 0.005) ( Figure 2B ). The correlation analysis between the number of lymphocytes in IT and PT areas revealed a medium positive association between either CD4+ or CD8+ cells in correspondence to HCC, whereas in LM the results indicated a weak relationship for both subtypes of T lymphocytes (Figure 3) . Figures 2A, B) , the association between the defined subgroups and clinical variables (Table 2) was tested; age > 63 was partially connected with decreased number of both populations of T lymphocytes. Moreover, we observed that decreased number of CD4+ cells within metastasized cancer islets was associated with increased number of lobes in LM.
Quantitative analysis of T cell populations in HCC and LM
When the threshold values were applied for T cells' populations according to mean values (bars in
Survival analysis
Based on Cox survival test and Kaplan-Meier plot we observed that the advanced stages (III and IV) in HCC and loss of histological differentiation (poor and undifferentiated grade) in LM are connected with shorter median OS rate (Figure 4) . When we focused on T cells populations, the decreased number of CD8+ cells in area surrounding tumor in LM was associated with shorter OS (Figure 4) . We also checked the PFS rates and no associations were found, neither based on clinical or morphological data.
Cox hazard test analysis revealed no significant relationship between variables and OS with the exception of HCC TNM staging. On the contrary, for LM we found that decreased number of peritumoral CD8+ lymphocytes may have independent prognostic value in LM cases with poorly or undifferentiated grade (Table 3) . Again, for PFS data we found no connections with clinical and morphological findings.
Discussion
Despite the current knowledge on the complex behavior of TILs in the hepatic microenvironment [20, 38, 39] , several issues are still in debate. It is unanimously accepted that the immune cells may inhibit the tumor growth and progression by malignant cells recognition and elimination, processes defined as immunesurveillance [40, 41] . If immunesurveillance www.fhc.viamedica.pl fails, the tumor cells could be either chronically preserved or modified by the interactions with immune cells, generating new tumor variants able to escape the immune system by several mechanisms [40, 41] . Therefore, the immunodeficient status may facilitate the risk of tumor development -an event amplified www.fhc.viamedica.pl also by the tumor potential to generate an immunosuppressive microenvironment which prevents the antitumor immunity. The variability of the cellular and molecular cross-talk in tumor microenvironment (yet impossible to quantify) directly induces the variability of the antitumoral or/and protumoral capacity expression. As a consequence, the mechanisms which regulate TILs pro-or antitumoral activity have not been satisfactorily understood.
Within this context, we focused on the study of CD4+ and CD8+ T lymphocytes present in the hepatic microenvironment in two different conditions, namely HCC -as a primary tumor -and liver metastases. Our comparative analysis aimed to identify the similarities and differences between the lymphocytes' numbers in intra-and peritumoral tissues (including the relationship with survival) in the progression of primary and secondary tumor, respectively.
Despite the differences in the pathomechanisms of the primary or secondary neoplastic process, we noted a similar pattern of T lymphocytes' distribution in HCC and LM, characterized by a higher number of both major types of T cells in PT area, at the invasive front, and their lower number inside the tumor tissue. Such observation has been refined by the separate quantitative assessment of CD4+ and CD8+ lymphocytes and statistical analysis that outlined two important differences between HCC and LM.
Firstly, HCC presented a quite similar number of CD4+ and CD8+ lymphocytes, whereas in LM the number of CD8+ cells was approximately twice than CD4+ lymphocytes. These data obviously indicates a different behavior of CD4+ and CD8+ lymphocyte subpopulations in primary versus secondary liver tumors. Quantitative arguments which attest CD8+ prevalence in LM suggest a stronger antitumor defense reaction in comparison to HCC. A possible explanation of enhanced CD8+ cells number in LM than in HCC may be related to the increased tumor angiogenesis in metastases [42] [43] [44] and to the intrinsic relationship between proangiogenic factors and TILs [45, 46] .
Secondly, we noted the significant decrease of both CD4+ and CD8+ cells within liver tumor as compared to its margin. Such observation supports the cross-talk between cancer and liver microenvironment [47] and the indirect tumor-T cell "fatal" relationship may develop at least in two ways. Fas-dependent induced apoptosis of activated T cells may be induced by tumoral cells expressing FasL. Such FasL-counterattack was found in non--small cell lung [48] and kidney cancer [49] , but it is also characteristic for metastatic colorectal cancer (CRC) [50] . Since CRC was primary tumor site in most patients with liver metastases we suppose that this tumor-lymphocyte relation may have strong connections with decreased number of intratumoral T lymphocytes in LM in comparison to HCC.
Another possible mechanism related to the low number of CD8+ cells may be associated with the presence of B7-H1 signaling molecule on tumor-infiltrating macrophages (TAMs) [51] . It was noted that TAMs play important role in tumor development and progression in liver [47] . TAMs are lured and activated by cancer cells, which secrete either M-CSF (macrophage colony stimulating factor) [47] or/and CEA (carcinoembryonic antigen) [52] . Our previous report showed that number of TAMs in LM was associated with overall survival (OS) [53] . TAMs were found as a main source of B7-H1 signaling molecule, which connects to PD-1 death receptor on activated CD8+ cells and therefore induces their apoptosis [51] . Since the number of T cells is much higher in the peritumoral tissue, we suppose that the T-cell specific pro-apoptotic signals triggered by cancer cells play a main role in the decrease of number of T cells in liver tumors, regardless of cancer origin.
Furthermore, the important role of CD8+ cells in inhibition of tumor progression was proven by survival analysis, since decreased number of CD8+ lymphocytes was associated with shorter OS in patients with liver metastases. Our results supplement the reports by other authors that support the positive prognosis value of CD8+ T lymphocytes in LM [33] [34] [35] .
Concerning the relationship between the lymphocytes and clinicopathological parameters, our data showed lack of correlations, except for the reduced number of CD8+/CD4+ lymphocytes and age over 63 or 68 years for HCC and LM respectively, and for the decreased number of intratumoral CD4+ lymphocytes and the increase of lobular extension in LM. These results reflect the difficulty to confirm the direct connection of lymphocytes to the clinical behavior of the tumors, either primary or secondary.
Finally, the main question that rises is related to the mechanisms that govern different antitumoral responses in primary and secondary tumors, respectively. Based on the above mentioned results, we can reiterate the intervention of the tumor FasL-counterattack or B7-H1 secretion.
Moreover, the absence of the correlation between TILs and survival in HCC can be interpreted as a consequence of an intense loss of lymphocytes through the proapoptotic processes that develop in the microenvironment of liver parenchyma. It is possible that in HCC these processes act on CD4+ and CD8+ T cells both in intra-and peritumoral tissue (and not only on IT lymphocytes as in LM www.fhc.viamedica.pl possibility offers new alternative for understanding lymphocytes' role in primary and secondary tumor progression than the widely-held paradigm based on the intratumoral balance between regulatory and cytotoxic T lymphocytes [20, 38, 39] and the obligatory role of CD4+ T cells recruitment for the induction of an efficient antitumoral action of CD8+ T cells [35] .
A special remark is compulsory to justify the methodology of our study that uses only the immunohistochemical assessment of the lymphocytic populations. At a glance, the absence of the advanced molecular biology techniques (e.g. cytometric analysis of tissue homogenates that can offer by ex vivo manipulation a better understanding of the in vivo cellular expression [54] could be considered as a major limitation for the obtained results. However, the morphological approach is much better suited for the identification and counting of CD4+ and CD8+ lymphocytes in their proper location in liver parenchyma, as shown by us for intra-and peritumoral territories. This approach made it possible to perform analysis of the correlation between the T lymphocytes' number and survival due to the use of the archived tumoral tissues.
